Paion Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Paion Stock Forecast and Price Target
In recent months, notable analysts have provided yearlong price targets for Paion, with the average target coming in at 0.02€. If it were to be achieved, this would result in a potential downside of approximately -33.33 percent from the most recent closing price in May, 2024. The high end is 0.02€, and the low is 0.01€. If you are not interested in PA8 stock, you may still be interested in its competitors and their current standings.
-33.33% Downside
Paion Fair Value Forecast for 2023 - 2025 - 2030
Paion's Price has decreased by 100.00% In the last three years, from 4.50€ to 0.00€. In the next year, analysts believe that Fair Value will reach 0.03€ – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BNTX Stock Forecast | BioNTech | Outperform |
12
|
$89.95 | Buy/Sell | $123.75 | 11.77% |
| MOR Stock Forecast | MorphoSys | Outperform |
6
|
66.20€ | Buy/Sell | 28.78€ | 2.72% |
| EVT Stock Forecast | Evotec | Outperform |
14
|
9.74€ | Buy/Sell | 37.33€ | 161.81% |
| BIO3 Stock Forecast | Biotest | Hold |
9
|
29.30€ | Buy/Sell | 37.00€ | 26.28% |
| IMTX Stock Forecast | Immatics N.V. | Buy |
4
|
$10.81 | Buy/Sell | $19.83 | 85.01% |
Paion Revenue Forecast for 2023 - 2025 - 2030
Paion's Revenue has seen impressive growth In the last two years, rising from 19.66€M to 33.25€M – a growth of 69.13%. In the following year, the 2 analysts surveyed believe that Paion's Revenue will decrease by 17.11%, reaching 27.56€M. For the next seven years, the forecast is for Revenue to grow by 8.91%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FYB Stock Forecast | Formycon | Buy |
11
|
40.95€ | Buy/Sell | 106.60€ | 119.78% |
| CVAC Stock Forecast | CureVac N.V. | Outperform |
6
|
$2.65 | Buy/Sell | $12.92 | 175.47% |
| HPHA Stock Forecast | Heidelberg Pharma | Buy |
11
|
3.01€ | Buy/Sell | 6.70€ | 275.42% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VSC Stock Forecast | 4SC | - |
4
|
7.90€ | Buy/Sell | 17.10€ | -100.00% |
| V3V Stock Forecast | VITA 34 | Hold |
10
|
4.94€ | Buy/Sell | 5.21€ | 7.29% |
| IFRX Stock Forecast | InflaRx N.V. | Outperform |
4
|
$1.41 | Buy/Sell | $9.44 | 390.78% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AFMD Stock Forecast | Affimed N.V. | Buy |
7
|
$5.33 | Buy/Sell | $5.25 | 203.00% |
| BNN Stock Forecast | BRAIN Biotech | Buy |
8
|
2.80€ | Buy/Sell | 11.23€ | 342.86% |
| MDG1 Stock Forecast | Medigene | Buy |
6
|
1.38€ | Buy/Sell | 2.68€ | 94.20% |
Paion EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Paion's EBITDA has seen an increase, rising from 2.39€M to 3.23€M. This represents a growth of 35.15%. For the next year, 2 analysts project Paion's EBITDA to drop by 64.71%, reaching 1.14€M. Over the next seven years, experts predict that Paion's EBITDA will grow at a rate of 103.84%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 2INV Stock Forecast | 2invest | - |
0
|
7.50€ | Buy/Sell | 29.70€ | -100.00% |
| VVY Stock Forecast | Vivoryon Therapeutics N.V. | Outperform |
4
|
0.65€ | Buy/Sell | 34.38€ | 9130.77% |
| ALTME Stock Forecast | TME Pharma N.V. | - |
-23
|
0.26€ | Buy/Sell | 3.52€ | -100.00% |
Paion EBIT Forecast for 2023 - 2025 - 2030
Paion's EBIT has seen growth In the last two years, going from 1.58€M to 2.22€M – a gain of 40.51% According to 2 prominent analysts, Paion's EBIT will fall by 98.20% in the next year, reaching 40.00€k. For the next seven years, the forecast is forEBIT to grow by 1566.67%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DBI Stock Forecast | Deutsche Biotech Innovativ | - |
6
|
1.35€ | Buy/Sell | 43.60€ | -100.00% |
| T5O Stock Forecast | bioXXmed | - |
4
|
0.49€ | Buy/Sell | 3.10€ | -46.94% |
| MGNK Stock Forecast | Mologen | - |
0
|
0.08€ | Buy/Sell | 0.00€ | -100.00% |
Paion EPS Price Prediction Forecast for 2023 - 2025 - 2030
Paion's EPS has decreased by 100.00% In the last three years, from 0.30€ to 0.00€. In the next year, analysts believe that EPS will reach -0.24€ – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SBH Stock Forecast | Sangui Biotech International | - |
0
|
0.00€ | Buy/Sell | 0.00€ | 0.00% |
| CNW Stock Forecast | co.don | - |
8
|
0.02€ | Buy/Sell | 6.30€ | -100.00% |
| MF6 Stock Forecast | MagForce | - |
7
|
0.00€ | Buy/Sell | 11.86€ | 0.00% |
.jpg)